RECENT PLACEMENT

Occam Places John Reynders as Chief Data Sciences Officer of Neumora

Occam Places John Reynders as Chief Data Sciences Officer of Neumora

Neumora Therapeutics, an Arch Venture Partners' investment leveraging ML to develop CNS drugs, emerged from stealth mode in 2021 with $500M in financing.

In 2020, Occam placed John Reynders, PhD, as the company's first Chief Data Sciences Officer. Prior to Neumora, John served as Vice President, data sciences, genomics and bioinformatics at Alexion, where he led the design, building and deployment of data sciences solutions spanning R&D, commercial, strategy and business development. Prior to joining Alexion, John served as the founding Chief Information Officer of Moderna Therapeutics.

‍

Related Placements

  1. Suzanne “Sue” Bruhn CEO of Prominent Rare Disease Research Foundation
  2. Vatnak Vat-Ho as CBO at Ryvu Therapeutics
  3. Steve Colletti as CSO of Korro Bio
  4. Theo Karaletsos as VP, Data Science/ML at insitro
  5. Sana Hafeez as Head of People at Unlearn
About Occam Global

Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.